AI Ethics, Regulation, Education & Emerging Frontiers

Session Overview

As artificial intelligence becomes embedded in clinical practice, drug development, public health systems, and biomedical research, the questions of how it should be governed, validated, and taught are no longer peripheral concerns — they are central to whether the field fulfills its potential responsibly and equitably. This session addresses the full lifecycle of responsible AI in healthcare and life sciences, from the design principles of fair and explainable systems through to post-deployment monitoring, regulatory compliance, medico-legal accountability, and the preparation of a workforce capable of working effectively alongside AI. It also examines the emerging technological frontiers — large language models, generative AI, and next-generation AI architectures — that will define the field through and beyond 2027.

This session features a keynote lecture, four oral presentations, and a poster presentation segment bringing together ethicists, regulatory scientists, clinical informaticists, educators, and researchers working at the governance and future frontiers of healthcare AI.

Why This Session Matters Now

The European Union AI Act, now entering its implementation phase, represents the most comprehensive legislative framework for AI governance yet enacted, with direct implications for every healthcare AI developer and deployer operating within or exporting to European markets. Simultaneously, regulatory agencies responsible for medical device approval are developing new guidance frameworks for AI-based software, including requirements for transparency, post-market surveillance, and predetermined change control. The emergence of large language models in clinical settings — from automated clinical documentation to diagnostic reasoning support — has introduced capabilities and risks that existing regulatory and ethical frameworks were not designed to address. For the research and clinical community, 2027 represents an inflection point: the decisions made now about how to validate, govern, and deploy healthcare AI will shape the trust and utility of these technologies for decades.

Key Scientific & Technical Themes

Algorithmic Fairness, Bias & Health Equity in AI Systems

AI systems trained on historical healthcare data inherit and can amplify the biases embedded in that data — disparities in diagnostic accuracy, treatment recommendation, and risk stratification that systematically disadvantage patients from underrepresented populations. Algorithmic fairness research is developing frameworks for identifying, measuring, and mitigating bias across the full pipeline of AI system development, from training data curation through model architecture to deployment monitoring. Health equity implications of AI extend beyond algorithmic bias to encompass differential access to AI-enhanced care, the representation of diverse populations in training datasets, and the risk that automation may reduce rather than improve equity in healthcare delivery. This theme examines the methodological, ethical, and policy dimensions of fairness in healthcare AI, including the standards and regulatory expectations that are emerging in response to documented equity failures.

Explainability, Transparency & Trustworthy AI Frameworks

The opacity of many high-performing AI models — particularly deep neural networks — creates a fundamental tension with the transparency requirements of clinical medicine, where practitioners must understand and be accountable for the basis of their decisions. Explainability methods, including attention visualization, saliency mapping, counterfactual explanation, and concept-based interpretation, are advancing the capacity to generate human-interpretable accounts of model behavior, though the clinical utility and reliability of these explanations remain active areas of investigation. Trustworthy AI frameworks — encompassing principles of transparency, robustness, human oversight, and accountability — are being translated into operational standards by regulatory bodies and standards organizations. Human-in-the-loop system design, which preserves meaningful clinician agency in AI-assisted decision processes, is increasingly recognized as a design requirement rather than an optional feature. This theme addresses the technical, clinical, and governance dimensions of explainability and trust in healthcare AI.

Regulation, Governance, Model Auditing & Post-Deployment Monitoring

The regulatory landscape for healthcare AI is undergoing rapid and consequential change, with the EU AI Act, medical device software regulations, and sector-specific guidance creating a complex and evolving compliance environment for developers, deployers, and clinical institutions. Model auditing — the systematic evaluation of AI system performance, fairness, robustness, and safety against defined standards — is emerging as a core component of both pre-market approval and post-deployment governance. Clinical AI benchmarking, using standardized evaluation datasets and performance metrics, is enabling meaningful comparison of systems across development environments. Post-deployment monitoring requirements — including ongoing performance surveillance, drift detection, and adverse event reporting — are creating new obligations for institutions that deploy AI in clinical care. AI liability and medico-legal frameworks are being actively developed by legal systems and professional bodies to address accountability when AI-assisted decisions contribute to patient harm. This theme provides a comprehensive examination of the regulatory, governance, and compliance dimensions of healthcare AI deployment.

AI in Medical Education, Training & Workforce Development

The integration of AI into healthcare practice demands a corresponding transformation in how clinicians, researchers, and health professionals are educated and trained. Medical curricula are beginning to incorporate AI literacy — covering the principles of machine learning, the interpretation of AI-generated outputs, and the critical appraisal of AI evidence — as a core competency for future practitioners. AI-driven simulation and adaptive learning platforms are creating new modalities for clinical skills training, procedural rehearsal, and continuing professional development. The challenge of preparing an existing clinical workforce for effective collaboration with AI tools — addressing both technical literacy and the psychological dimensions of human-AI trust — is a pressing implementation science question. This theme examines the pedagogical frameworks, curriculum design, and educational technology innovations that are shaping AI-ready healthcare workforce development.

Large Language Models, Generative AI & Emerging Frontiers in Healthcare

The rapid advancement of large language models and generative AI represents the most significant shift in the technological landscape of healthcare AI since the deep learning revolution of the early 2010s. In clinical settings, LLMs are being evaluated for automated clinical note generation, diagnostic reasoning support, patient communication, and medical knowledge synthesis — applications that simultaneously offer substantial efficiency gains and introduce novel risks around hallucination, factual accuracy, and clinical accountability. Generative AI in drug discovery, protein structure prediction, and synthetic data generation for model training is advancing the frontiers of computational biology and personalized medicine. Foundation models capable of integrating multimodal clinical data — text, imaging, genomics, and time-series physiological data — represent an emerging paradigm that may fundamentally reshape the architecture of clinical AI systems. This theme examines the capabilities, limitations, safety considerations, and governance implications of LLMs and generative AI across healthcare and life science applications.

Research Landscape & Data Trends

AI ethics, regulation, and governance in healthcare has evolved rapidly from a largely philosophical discourse into an applied research domain generating empirical evidence about algorithmic bias, explainability method performance, regulatory framework design, and implementation outcomes. The literature is characterized by increasing methodological rigor — moving from position papers and framework proposals toward empirical studies measuring the equity, transparency, and clinical impact of deployed AI systems. Large language model research in healthcare settings is the most rapidly expanding subfield, with an explosion of studies evaluating clinical NLP, automated documentation, and diagnostic reasoning applications. Regulatory science for healthcare AI is producing an increasingly codified body of guidance, with active harmonization efforts between major regulatory jurisdictions. By 2027, post-deployment surveillance methodologies, AI liability case law, and LLM safety evaluation frameworks are expected to represent the most consequential emerging areas of the field.

Who Should Attend

  • Bioethicists, clinical ethicists, and health policy researchers working on AI governance frameworks and equity
  • Regulatory scientists and medical device professionals navigating AI Act, software as a medical device, and related compliance frameworks
  • Clinical informaticists and AI developers responsible for model auditing, validation, and post-deployment monitoring
  • Medical educators and curriculum developers integrating AI literacy into health professional training programs
  • Health law and medico-legal professionals addressing AI liability, accountability, and professional responsibility
  • Machine learning researchers working on explainability, fairness, robustness, and trustworthy AI methodology
  • NLP researchers and clinical AI developers working with large language models in healthcare applications
  • Hospital executives, chief medical officers, and clinical governance leads responsible for AI deployment oversight
  • Patient advocates and representatives engaging with the equity and transparency dimensions of clinical AI
  • Researchers and practitioners at the intersection of AI innovation and responsible implementation across all healthcare domains

Session Perspective

The technical capability of AI in healthcare has advanced faster than the governance, regulatory, and educational infrastructure required to deploy it responsibly and equitably. This session reflects the conviction that closing this gap is not a constraint on innovation — it is a prerequisite for the durable trust that will determine whether AI ultimately transforms healthcare for the better. The most consequential work in this field requires deep collaboration between technologists, clinicians, ethicists, regulators, and patients. Researchers, practitioners, and policymakers who are doing this work — and who recognize that the future of healthcare AI depends as much on how it is governed as on how it performs — are invited to bring their perspectives to this session.

If your research aligns with this session, we invite you to submit an abstract for consideration.